Related Experiment Video
Updated: Aug 6, 2025

06:05
Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
Published on: July 21, 2023
590
Temporomandibular Disorder Treated With Chiropractic Therapy.
Eric Chun-Pu Chu1, Wai Ting Lee1, Cherie Chau1
1Department of Chiropractic, New York Medical Group, EC Healthcare, Kowloon, HKG.
Cureus
|March 22, 2023
Summary
Chiropractic therapy, including spinal adjustments and exercise, effectively treated temporomandibular disorders (TMDs). A patient experienced symptom resolution and improved quality of life after four weeks of chiropractic care for TMD.
Area of Science:
- Chiropractic medicine
- Musculoskeletal disorders
- Rehabilitation
Background:
- Temporomandibular disorders (TMDs) are prevalent conditions affecting the temporomandibular joint (TMJ) and associated musculoskeletal structures.
- Conventional treatments for TMDs include physiotherapy, occlusal splints, orthodontics, and electrotherapy.
- Chiropractic therapy is an emerging non-invasive treatment for TMDs.
Observation:
- A case study involved a 39-year-old female patient diagnosed with TMD.
- The patient received chiropractic therapy, encompassing spinal adjustments, soft tissue manipulation, and exercise rehabilitation.
- Treatment duration was four weeks, followed by monthly maintenance for six months.
Findings:
- The patient achieved complete symptom resolution within four weeks of chiropractic treatment.
- Significant improvements were noted in the patient's quality of life score.
- Long-term follow-up revealed sustained symptom absence and enhanced spinal range of motion, open-mouth posture, and cervical lordosis.
Implications:
- This case study suggests chiropractic therapy is a potentially effective treatment for managing TMD.
- An interdisciplinary approach integrating chiropractic care may offer benefits for TMD patients.
- Chiropractic therapy presents a promising non-pharmacological option for TMD management.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
1.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.7K
Tonsillitis II: Management
151
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
151

